Related references
Note: Only part of the references are listed.STAT3 can serve as a hit in the process of malignant transformation of primary cells
M. Demaria et al.
CELL DEATH AND DIFFERENTIATION (2012)
mTOR Pathway Overactivation in BRAF Mutated Papillary Thyroid Carcinoma
Alexandra Faustino et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Cytoprotection by the modulation of mitochondrial electron transport chain: The emerging role of mitochondrial STAT3
Karol Szczepanek et al.
MITOCHONDRION (2012)
Pyruvate Kinase M2 Regulates Gene Transcription by Acting as a Protein Kinase
Xueliang Gao et al.
MOLECULAR CELL (2012)
Hypoxia-induced SOCS3 is limiting STAT3 phosphorylation and NF-κB activation in congenital heart disease
Qiang Gu et al.
BIOCHIMIE (2011)
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Weibo Luo et al.
CELL (2011)
From the nucleus to the mitochondria and back The odyssey of a multitask STAT3
Marco Demaria et al.
CELL CYCLE (2011)
Environment, inflammation, and cancer
Pasquale Sansone et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
p19ARF/p1ARF Controls Oncogenic Functions of Signal Transducer and Activator of Transcription 3 in Hepatocellular Carcinoma
Doris Schneller et al.
HEPATOLOGY (2011)
Desmoplastic stromal reaction in papillary thyroid microcarcinoma
Oskar Koperek et al.
HISTOPATHOLOGY (2011)
Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice
Aime T. Franco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype
Hiromu Suzuki et al.
CARCINOGENESIS (2010)
Nuclear Localization of Signal Transducer and Activator of Transcription 3 in Head and Neck Squamous Cell Carcinoma Is Associated with a Better Prognosis
Eirini Pectasides et al.
CLINICAL CANCER RESEARCH (2010)
IGFBP7: an oncosuppressor gene in thyroid carcinogenesis
M. G. Vizioli et al.
ONCOGENE (2010)
Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation
Kenneth Leslie et al.
BREAST CANCER RESEARCH (2010)
The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
Michael Hedvat et al.
CANCER CELL (2009)
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
Sergei Grivennikov et al.
CANCER CELL (2009)
Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA, and AKT1
Julio C. Ricarte-Filho et al.
CANCER RESEARCH (2009)
Transcriptome analysis in mouse tumors induced by Ret-MEN2/FMTC mutations reveals subtype-specific role in survival and interference with immune surveillance
D. Engelmann et al.
ENDOCRINE-RELATED CANCER (2009)
Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell lines
Narendra Wajapeyee et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Analysis of the Association between CIMP and BRAFV600E in Colorectal Cancer by DNA Methylation Profiling
Toshinori Hinoue et al.
PLOS ONE (2009)
Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation
Daniel J. Gough et al.
SCIENCE (2009)
Function of Mitochondrial Stat3 in Cellular Respiration
Joanna Wegrzyn et al.
SCIENCE (2009)
Molecular pathology of thyroid cancer: diagnostic and clinical implications
James A. Fagin et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Reactivation of IGFBP7 by DNA demethylation inhibits human colon cancer cell growth in vitro
Jie Lin et al.
CANCER BIOLOGY & THERAPY (2008)
Fibroblasts Isolated from Common Sites of Breast Cancer Metastasis Enhance Cancer Cell Growth Rates and Invasiveness in an Interleukin-6-Dependent Manner
Adam W. Studebaker et al.
CANCER RESEARCH (2008)
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7
Narendra Wajapeyee et al.
CELL (2008)
Cancer cell metabolism: Warburg and beyond
Peggy P. Hsu et al.
CELL (2008)
Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer
Mabel Ryder et al.
ENDOCRINE-RELATED CANCER (2008)
STAT3 inhibits the degradation of HIF-1α by pVHL-mediated ubiquitination
Joo Eun Jung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2008)
Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway
Nuria de la Iglesia et al.
GENES & DEVELOPMENT (2008)
Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1α RNA expression in both tumor cells and tumor-associated myeloid cells
Guilian Niu et al.
MOLECULAR CANCER RESEARCH (2008)
Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression
Jennifer S. Fang et al.
SEMINARS IN CANCER BIOLOGY (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas
Sizhi Paul Gao et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines
Ana Margarida Meireles et al.
THYROID (2007)
Molecular genetics of papillary thyroid carcinoma -: Great expectations ...
Vitor Trovisco et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2007)
Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer
Marjan Berishaj et al.
BREAST CANCER RESEARCH (2007)
In-vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancer
Abram Vaccaro et al.
ANTI-CANCER DRUGS (2006)
The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells
Hidetoshi Sumimoto et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Role of STAT3 in type I interferon responses - Negative regulation of STAT1-dependent inflammatory gene activation
Hao H. Ho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Sulforhodamine B colorimetric assay for cytotoxicity screening
Vanicha Vichai et al.
NATURE PROTOCOLS (2006)
Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene
MG Borrello et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
Q Xu et al.
ONCOGENE (2005)
RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response
E Puxeddu et al.
ENDOCRINE-RELATED CANCER (2005)
A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells
L O Flowers et al.
ONCOGENE (2005)
RET-familial medullary thyroid carcinoma mutants Y791F and S891A activate a Src/JAK/STAT3 pathway, independent of glial cell line-derived neurotrophic factor
IP Menacho et al.
CANCER RESEARCH (2005)
IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells
EJ Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC
P Soares et al.
ONCOGENE (2003)
Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: Roles in specific gene regulation and cellular transformation
JH Hwang et al.
MOLECULAR ENDOCRINOLOGY (2003)
Cobalt inhibits the interaction between hypoxia-inducible factor-α and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-α
Y Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway
JI Park et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
MEN2A-RET-induced cellular transformation by activation of STAT3
JJ Schuringa et al.
ONCOGENE (2001)